Select Page

3D printed nanoparticle biosensing platform detects SARS-CoV-2 antibodies within seconds

3D printed nanoparticle biosensing platform detects SARS-CoV-2 antibodies within seconds

Written by David

September 17, 2020

Pandemics caused by novel infectious agents like the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Zika, or Ebola virus seriously impact human health and lives while also overwhelming health care systems all over the world. Early detection and diagnosis allow isolation of the infected patients and contact tracing, which can mitigate the spread of the virus and save lives, especially when a significant number of the patients are asymptomatic.

 .

Current methods used in SARS-CoV-2 detection Developing low-cost and rapid testing methods for early detection of infection has always been a challenge while dealing with the current COVID-19 pandemic. Presently, two approaches are being used for the detection of COVID-19 infection. The first one detects the viral genome and uses techniques such as genomic sequencing, CRISPR, and reverse transcription real-time quantitative polymerase chain reaction (PCR). While these methods are relatively accurate, they are slow because there are multiple steps involved […]

0 Comments

Submit a Comment

Your email address will not be published. Required fields are marked *

You May Also Like…

Pin It on Pinterest

Share This

Share this post with your friends!

Shares